Novel targets and approaches in advanced prostate cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference63 articles.
1. Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer
2. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
3. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
4. Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis
5. Mechanisms of the development of androgen independence in prostate cancer
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. FS-7 inhibits MGC-803 cells growth in vitro and in vivo via down-regulating glycolysis;Biomedicine & Pharmacotherapy;2019-01
2. Macranthoside B Induces Apoptosis and Autophagy Via Reactive Oxygen Species Accumulation in Human Ovarian Cancer A2780 Cells;Nutrition and Cancer;2016-02-17
3. Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors;Proceedings of the National Academy of Sciences;2015-03-11
4. Building on Prostate Cancer Working Group 2 to Change the Paradigm from Palliation to Cure;American Society of Clinical Oncology Educational Book;2014-05
5. Antitumor Effects of Saffron-Derived Carotenoids in Prostate Cancer Cell Models;BioMed Research International;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3